This page shows the latest autoimmune disease news and features for those working in and with pharma, biotech and healthcare.
According to the company, Tavalisse targets the underlying autoimmune cause of the disease by impeding platelet destruction, providing “an important new treatment option for adult patients with chronic ITP”. ... Rigel is also developing it for
No decision has yet been taken on other autoimmune disease indications for the drug, such as lupus, lupus nephritis, and Sjögren’s syndrome, according to analyst Hur Hye-min of Hi ... Celgene was developing a BTK inhibitor for autoimmune diseases
The US regulator gave the go-ahead yesterday to use Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease that causes vasculitis, inflammation in ... GSK’s drug is the first to
Principa’s lead BTK drug is PRN1008, which is in phase II testing for autoimmune disease pemphigus vulgaris.
Given in combination with methotrexate, the twice-daily administered drug is recommended for adults whose disease hasn’t responded adequately to intensive therapy with conventional or other disease-modifying anti-rheumatic ... According to the National
We are excited about the opportunity to bring Soliris to patients who continue to suffer from this debilitating disease despite current therapies.”. ... While most symptoms in gMG - a chronic and progressive autoimmune disease - can be managed with
More from news
Approximately 3 fully matching, plus 51 partially matching documents found.
Autoimmune conditions such as Crohn’s disease can flare up through an imbalance of things like stress, lack of sleep or overworking - not just as a direct consequence of nonadherence to
Transformative medicine use. The overwhelming inertia in medicine use - where 97% of medicines used have been available for more than ten years - masks the contribution from transformative disease treatments, orphan drugs ... Disease treatments in 2020
Lumena develops oral products for treating liver disease and has two oral inhibitors of the apical sodium-dependent bile acid transporter (ASBT) in phase II to improve liver function. ... MGD010 a B-cell targeted monoclonal antibody for treatment of
The report found that the economic impact of a rare disease can be truly devastating. ... A UK patient with mixed connective tissue disease (an autoimmune rare disease which has the signs and symptoms of lupus, scleroderma, polymyositis, and rheumatoid
During this month, we saw transactions across a range of therapeutic and disease areas (including autoimmune, haematology, metabolic, dermatology) with branded, OTC, generics and biosimilars all represented. ... Autoimmune options. Elan-Biogen's deal was
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
His expertise has seen him led transactions across a broad span of deal-types, geographies, and therapeutic disease areas and he brings experience in business and corporate development, finance, marketing and ... As Akari continues its mission to develop
and commercialisation of orphan autoimmune and inflammatory disease treatments.
Dr Payton joins the metabolic disease specialist - a spin-out company from the Universities of Glasgow and Southern Denmark - from MAPBiotech, where he has served as chief executive officer since 2014. ... He co-founded autoimmune disease-focused Orca
In his new position at autoimmune disease specialists SuppreMol, Schollmeier succeeds Professor Peter Buckell who retires. ... He said: "The company has a very promising product candidate for the treatment of autoimmune diseases in phase II clinical
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Patient Persepective: Autoimmune Disease. Autoimmune diseases affect 1– 5% of the World’ s population and have varied symptoms and causes. ... Here we explore with Lois what it is like to live with the symptoms of autoimmune disease, including
Silver Winner - Random 42 for Systematic Lupus Erythematosus. This animation highlights the pathogenesis of Lupus, an autoimmune disease where the body’ s own immune system attacks healthy tissue.
A panel of 200 gastroenterologists will report in 10 IBD patient record forms each quarter (5 Crohn’ s disease and 5 ulcerative colitis), to monitor the evolving IBD treatment landscape.
More from PMHub
Approximately 2 fully matching, plus 1 partially matching documents found.
Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...